Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon

Pioneering study by award-winning Children’s Hospital of Michigan and Wayne State University researcher shows many kids with cardiomyopathy can regain heart health

After two decades of arduous research, a National Institutes of Health (NIH)-funded investigator at the Children’s Hospital of Michigan (CHM) at the Detroit Medical Center (DMC) and the Wayne State University School of Medicine has published a new study showing that many children with an often fatal type of heart disease can recover “normal size and function” of damaged sections of their hearts.

Abbott's first-of-its-kind MitraClip device now approved in Canada

Abbott today announced that its revolutionary, catheter-based MitraClip(r) therapy has received Health Canada approval, providing physicians in Canada with a breakthrough treatment option that can significantly improve symptoms, disease progression and quality of life for certain people with a heart condition called mitral regurgitation (MR).

Thumbnail

Heart Team Approach: Still a Work in Progress

The heart team approach is transforming how cardiovascular specialists and staff interact and provide patient care, but it also poses challenges in daily practice.

AATS: No signs of risk creep with TAVR

Fears that physicians may be treating patients who are suitable candidates for standard care with less invasive transcatheter aortic valve replacement (TAVR) may be allayed, based on results presented April 28 at the American Association of Thoracic Surgery meeting in Toronto.

AATS: Complex cardiac surgeries may require continued training

Cardiac surgeons may benefit from continuous training if they perform complex or rare procedures, according to an abstract presented April 28 at the American Association for Thoracic Surgery meeting in Toronto.

FDA approves valve treated to prevent calcification

The FDA approved a bioprosthetic heart valve that is treated to improve durability.

Thumbnail

Court grants delay on CoreValve injunction

Does CoreValve have a pulse? A federal court of appeals granted Medtronic’s request to delay implementation of a preliminary injunction that would limit the sale of the device in the U.S.

Thumbnail

Preventable complications

Joseph F. Sabik, III, MD, chairman of thoracic and cardiovascular surgery at the Cleveland Clinic, offers tips to reduce the chance of developing a surgical site infection from a cardiac operation in a video on the clinic’s HealthHub site.

Displaying 1257 - 1264 of 2350

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.